Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
1:22cv1411 • March 14, 2022
Class Period Start
June 28, 2018
Class Period End
September 2, 2020
PSLRA Deadline
May 13, 2022
Case Allegations
10b5
Statutes of Repose
Jun 28, 2021
Country
United States
Court
Federal Court
Sep 7, 2022
Voluntary Dismissal
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Aug 29, 2022
Voluntary Dismissal
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Jun 28, 2022
Appointment of Lead Plaintiff
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Mar 14, 2022
First Filed Complaint
A securities fraud class action complaint has been filed on behalf of certain investors in Akebia Therapeutics, Inc..
TOP
